Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 2.42B | $ 3.49B | $ 4.25B | $ 3.55B | $ 2.64B |
Total Assets | $ 14.30B | $ 16.22B | $ 16.01B | $ 14.51B | $ 13.33B |
Total Debt | $ 859.75M | $ 2.31B | $ 2.52B | $ 1.51B | $ 1.22B |
Net Debt | $ -1.56B | $ -1.18B | $ -1.72B | $ -2.04B | $ -1.42B |
Total Liabilities | $ 2.59B | $ 4.14B | $ 4.52B | $ 3.19B | $ 2.70B |
Stockholders Equity | $ 11.71B | $ 12.08B | $ 11.50B | $ 11.32B | $ 10.63B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |